👉Poster P222 on Tuesday, Oct 21:
“Sustained Muscle Function Improvement After a Single In Vivo Dose of Antibody Oligonucleotide Conjugate (AOC) in the mdx Mouse Model for Duchenne Muscular Dystrophy.”
👉Poster P222 on Tuesday, Oct 21:
“Sustained Muscle Function Improvement After a Single In Vivo Dose of Antibody Oligonucleotide Conjugate (AOC) in the mdx Mouse Model for Duchenne Muscular Dystrophy.”
Are you seeking a meaningful role where you can apply your expertise to advance the treatment of Duchenne muscular dystrophy? We have an opening for research technician position in our group:
www.lumc.nl/en/about-lum...
Are you seeking a meaningful role where you can apply your expertise to advance the treatment of Duchenne muscular dystrophy? We have an opening for research technician position in our group:
www.lumc.nl/en/about-lum...
Neurophysiological treatment effects of mesdopetam, pimavanserin and amantadine in a rodent model of levodopa-induced dyskinesia
www.authorea.com/users/837293...
Neurophysiological treatment effects of mesdopetam, pimavanserin and amantadine in a rodent model of levodopa-induced dyskinesia
www.authorea.com/users/837293...